Date | Title | Description | |
---|---|---|---|
29 Sep 2025 | On corporate transactions: mergers, acquisitions and others | ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) | Download |
29 Sep 2025 | On corporate transactions: mergers, acquisitions and others | The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) | Download |
24 Jul 2025 | On P&L | The Company releases the press release related to the first half of 2025 financial results | Download |
24 Jul 2025 | On P&L | The Company releases the first half 2025 financial results presentation | Download |
25 Mar 2025 | On business and financial situation | The Company releases the presentation related to its strategy update because of its 2025 Capital Markets Day | Download |
Pages
Date | Title | Description | |
---|---|---|---|
21 Oct 2021 | Liquidity and counterparty agreements | Download | |
21 Oct 2021 | On business and financial situation | The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). | Download |
07 Oct 2021 | Liquidity and counterparty agreements | Download | |
04 Oct 2021 | Liquidity and counterparty agreements | Download | |
01 Sep 2021 | On business and financial situation | ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine | Download |
Pages
Date | Title | Description | |
---|---|---|---|
03 Jul 2012 | Información sobre dividendos | Download | |
13 Jun 2012 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
26 Apr 2012 | Información sobre resultados (2) | Download | |
26 Apr 2012 | Información sobre resultados | Download | |
26 Apr 2012 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download |